Evoq Remedies Limited
BSE: EVOQ · Trading & Distributors · sector
Key numbers
Last 12 months to Mar 2026, Standalone. "Sector median" = middle value of 157 companies in Trading & Distributors (P/E median leaves out loss-making companies). Tap ? for what a number means.
Things to know
- Net loss in 1 of the last 3 quarters.
- No dividend in the last 5 financial years.
- Price ₹1.77 on 2026-10-26: -71.0% from the 52-week high, +31.1% from the 52-week low.
Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.
Charts
Quarterly results
| ₹ cr | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|
| Revenue | 12 | 26 | 0 |
| EBITDA | -1 | -1 | -0 |
| OPM % | -5.2% | -3.8% | – |
| Other income | 2 | 1 | 0 |
| Net profit | 2 | 0 | -0 |
| EPS (₹) | 0.69 | 0.02 | 0.12 |
Standalone figures where filed. Latest quarter Mar 2026.
Profit & loss (yearly)
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 | TTM |
|---|---|---|---|---|---|---|
| Revenue | 17 | 20 | 4 | 12 | 26 | 26 |
| EBITDA | 1 | -4 | -2 | -2 | -1 | -1 |
| Net profit | 1 | 2 | 0 | 0 | -0 | -0 |
| EPS (₹) | 0.70 | 1.19 | 1.25 | 0.04 | 0.10 | 0.10 |
| Revenue growth | +21.5% | -80.1% | +190.4% | +116.9% | – | |
| Profit growth | +48.6% | -72.2% | -91.1% | -700.0% | – | |
| Dividend / share (₹) | – | – | – | – | – |
| Compounded growth | 3 years | 5 years | Last 12 months |
|---|---|---|---|
| Sales | +7.7% | – | – |
| Net profit | – | – | – |
| EPS | -56.2% | – | – |
| Share price | – | -51.4% (2y) | -68.9% |
Balance sheet
| ₹ cr | FY25 | FY26 |
|---|---|---|
| Shareholders' equity | 20 | 19 |
| Cash & equivalents | 0 | 0 |
| Total assets | 50 | 52 |
| Fixed assets | 0 | 0 |
| Investments | 0 | 0 |
| Inventory | 2 | 2 |
Year-end figures from the March annual filing.
Cash flow
| ₹ cr | FY25 | FY26 |
|---|---|---|
| Cash from operations | -15 | -0 |
| Cash from investing | -0 | 0 |
| Cash from financing | 15 | 0 |
| Capex | 0 | 0 |
| Free cash flow | -15 | -0 |
Free cash flow = cash from operations − capex.
Ratios by year
| ₹ cr | FY25 | FY26 |
|---|---|---|
| ROE % | 0.2% | -1.2% |
| ROCE % | 0.7% | -1.3% |
| Inventory days | 62 | 24 |
| Working capital days | 1,376 | 631 |
Peers in Trading & Distributors
| Company | Market cap | P/E | P/B | ROE | ROCE | OPM | Sales 3y | Div yield |
|---|---|---|---|---|---|---|---|---|
| REDINGTON | ₹28,671 cr | 16.9x | 2.8x | 18.0% | 18.4% | 1.9% | +14.5% | 1.85% |
| MMTC | ₹7,599 cr | 17.0x | 3.6x | 23.4% | 25.6% | 10,805.5% | -90.1% | – |
| MSTCLTD | ₹4,097 cr | 17.5x | 4.5x | 28.5% | 30.1% | 61.1% | -20.0% | 1.30% |
| CNL | ₹1,607 cr | 24.7x | 4.4x | 22.4% | 16.3% | 3.6% | +25.2% | 0.05% |
| BNAGROCHEM | ₹1,267 cr | 45.5x | 2.7x | 4.0% | 0.7% | -0.5% | – | – |
| YSL | ₹757 cr | 8.3x | 0.6x | 7.1% | 0.3% | 2.1% | +0.3% | 2.03% |
| SHIVAUM | ₹738 cr | 64.9x | 6.1x | 10.2% | 11.3% | 3.1% | – | – |
| STCINDIA | ₹594 cr | 0.9x | 1.0x | 228.5% | 108.2% | – | – | – |
| PERVASIVE | ₹587 cr | 0.1x | 6.5x | -0.2% | -0.1% | -0.9% | – | – |
| EVOQ | ₹4 cr | 17.7x | 0.2x | -1.2% | -1.3% | -5.7% | +7.8% | – |
Documents
Links go to the original files on the exchange website.
About the company
| Sector | Services |
| Industry | Trading & Distributors |
| Sub-industry | Trading & Distributors |
| Symbol | EVOQ |
| BSE code | 543500 |
| ISIN | INE0JVD01011 |
| Face value | ₹10.0 |
| Incorporated | – |
| Website | – |
| Plants (India / abroad) | – |
Data built 2026-10-24 from BSE company filings (inline XBRL: Integrated Filing - Finance) + BSE results summary for earlier years; price = BSE close 2026-10-26.